Free Trial

O Shaughnessy Asset Management LLC Invests $301,000 in Doximity, Inc. (NASDAQ:DOCS)

Doximity logo with Medical background

O Shaughnessy Asset Management LLC acquired a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 5,632 shares of the company's stock, valued at approximately $301,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DOCS. Arrowstreet Capital Limited Partnership raised its holdings in shares of Doximity by 708.7% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,510,416 shares of the company's stock worth $80,641,000 after purchasing an additional 1,323,634 shares in the last quarter. QSV Equity Investors LLC boosted its stake in shares of Doximity by 0.3% during the 4th quarter. QSV Equity Investors LLC now owns 60,763 shares of the company's stock worth $3,244,000 after acquiring an additional 186 shares in the last quarter. Orion Portfolio Solutions LLC raised its position in shares of Doximity by 209.4% during the fourth quarter. Orion Portfolio Solutions LLC now owns 18,484 shares of the company's stock worth $987,000 after purchasing an additional 12,509 shares during the period. Pictet Asset Management Holding SA lifted its holdings in shares of Doximity by 547.0% during the fourth quarter. Pictet Asset Management Holding SA now owns 106,727 shares of the company's stock valued at $5,698,000 after purchasing an additional 90,232 shares during the last quarter. Finally, New Age Alpha Advisors LLC acquired a new position in shares of Doximity in the 4th quarter valued at $485,000. Institutional investors own 87.19% of the company's stock.

Doximity Stock Down 1.1 %

Shares of DOCS stock traded down $0.56 during trading hours on Thursday, reaching $52.22. 286,922 shares of the company's stock were exchanged, compared to its average volume of 1,971,411. The business has a fifty day moving average price of $64.00 and a 200-day moving average price of $55.61. The stock has a market capitalization of $9.75 billion, a P/E ratio of 52.36, a P/E/G ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Raymond James restated an "outperform" rating and issued a $83.00 price target (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. Bank of America increased their price objective on Doximity from $54.00 to $57.00 and gave the stock a "neutral" rating in a research note on Monday, January 6th. Mizuho lifted their target price on Doximity from $55.00 to $65.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Canaccord Genuity Group increased their price target on shares of Doximity from $60.00 to $71.00 and gave the stock a "hold" rating in a research report on Friday, February 7th. Finally, Leerink Partnrs raised shares of Doximity from a "hold" rating to a "strong-buy" rating in a research report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Doximity has a consensus rating of "Moderate Buy" and an average target price of $65.00.

Get Our Latest Analysis on DOCS

Insider Buying and Selling at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares of the company's stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 37.40% of the company's stock.

Doximity Company Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Articles

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines